Transcutaneous Electrical Nerve Stimulation on Pain Intensity of Patients

Status Completed

Clinical Trial Summary

Fifty patients with hip arthroplasty were purposively recruited for the study. They were allocated into two groups randomly with equal number. One group had TEN, other served as control. Pain intensity was measured every day of the treatment.

Clinical Trial Description

Subjects that participated were post-surgical patients with hip arthroplasty receiving treatment at Orthopedic Ward of Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC), Ile-Ife. Excluded from the study were subjects who had surgery but have infected wound, those with deep vein thrombosis, and those with thrombophlebitis post-surgery. The subjects were allocated randomly into 2 groups; one group of 25 patients was on TENS (experimental group) and the other group of 25 patients was on their normal drugs without TENS (control group). Before the start of intervention, the procedure of the intervention and the way the subject would feel during the course of the intervention was explained to the subject and the consent of the patient was obtained. The procedure was as follows:The Visual Analogue Scale and Oxford hip score was administered prior to the treatment to ascertain their pain level and hip disability before the treatment. The site of intervention (5cm away from incision site) was cleaned properly with cotton wool soaked in methylated spirit in an outward motion. Before the self-adhesive, pre gelled electrodes was placed on the cleansed sites. The TENS unit was switched on and the parameters was adjusted to the required. For this study, parameters used are: 100µs pulse duration, 100Hz frequency and an intensity comfortable for the patient for a duration of 15 minutes.

At the expiration of treatment, the electrodes were removed. The treatment was carried out twice a day for three days in addition to the normal analgesic and antibiotics drugs taken by the patient. After the last treatment session, VAS and Oxford hip score was re-administered to ascertain their pain intensity and hip disability level.

For the group with no intervention The VAS and Oxford hip score was administered on the first day of contact to ascertain pain intensity and hip disability level . The subject continued on the normal analgesics only till the third day and VAS and Oxford hip score was re-administered to ascertain their pain intensity and hip disability level. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03534999
Study type	Interventional
Source	Obafemi Awolowo University
Contact
Status	Completed
Phase	N/A
Start date	October 2, 2017
Completion date	February 16, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02507609` - Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium	N/A
Completed	`NCT03906864` - Care Pathway for Sub-acute Hip Rehabilitation	N/A
Recruiting	`NCT04063891` - Vibration Therapy as an Intervention for Enhancing Trochanteric Hip Fracture Healing in Elderly Patients	N/A
Completed	`NCT05039879` - Life Improving Factors After a Hip Fracture
Not yet recruiting	`NCT03887494` - Study of the Impact of the Femoral Implant "Y-strut" on Lytic Bone Metastases of the Femoral Neck (WAZA-ARY)	N/A
Terminated	`NCT03065101` - Trigen InterTAN vs Sliding Hip Screw RCT	N/A
Completed	`NCT03545347` - Physiotherapy, Nutritional Supplement and Anabolic Steroids in Rehabilitation of Patients With Hip Fracture.	Phase 2
Completed	`NCT03695081` - Patient Pathway Pharmacist - Optimal Drug-related Care	N/A
Recruiting	`NCT05971173` - Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery	Early Phase 1
Active, not recruiting	`NCT04957251` - Anterior vs Posterior Approach for Hip Hemiarthroplasty	N/A
Terminated	`NCT04372966` - Uncemented Versus Cemented Total Hip Arthroplasty for Displaced Intracapsular Hip Fractures	N/A
Withdrawn	`NCT05030688` - Fascia Iliaca Compartment Block and PENG Block for Hip Arthroplasty	N/A
Completed	`NCT04424186` - 'Rehabilitation for Life'	N/A
Not yet recruiting	`NCT04183075` - Impact of a Nutritional Supplement on the Recovery of the Nutritional Status of Patients With Spontaneous Hip Fracture	N/A
Withdrawn	`NCT05518279` - Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures	Phase 3
Not yet recruiting	`NCT02892968` - ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients	N/A
Not yet recruiting	`NCT02223572` - Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture	N/A
Active, not recruiting	`NCT02247791` - Uncemented Compared to Cemented Femoral Stems in Total Hip Arthroplasty	N/A
Completed	`NCT00746876` - Unipolar or Bipolar Hemiarthroplasty in the Treatment of Displaced Femoral Neck Fractures.	N/A
Completed	`NCT00058864` - The HIP Impact Protection Program (HIP PRO)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Transcutaneous Electrical Nerve Stimulation on Pain Intensity of Patients With Hip Arthroplasty — TENSHIParth

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms